SIMPLEX TRADING, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 4 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$5,946
+21.2%
131,000
+49.9%
0.01%
+25.0%
Q2 2023$4,906
+47.6%
87,400
+18.9%
0.00%
+33.3%
Q1 2023$3,324
+7.9%
73,500
-3.0%
0.00%0.0%
Q4 2022$3,081
-99.8%
75,800
+170.7%
0.00%
+50.0%
Q3 2022$1,829,000
-48.6%
28,000
-52.1%
0.00%
-50.0%
Q2 2022$3,555,000
-22.9%
58,500
-20.4%
0.00%0.0%
Q1 2022$4,613,000
-17.9%
73,500
-0.9%
0.00%
-33.3%
Q4 2021$5,622,000
-52.4%
74,200
-1.6%
0.01%
-45.5%
Q3 2021$11,810,000
-0.3%
75,400
+3.0%
0.01%0.0%
Q2 2021$11,850,000
+229.7%
73,200
+24713.6%
0.01%
+83.3%
Q1 2021$3,594,000
-43.2%
295
-28.6%
0.01%
-25.0%
Q4 2020$6,323,000
+113.6%
413
+16.7%
0.01%
+100.0%
Q3 2020$2,960,000
-17.6%
354
-27.6%
0.00%
-33.3%
Q2 2020$3,593,000
+89.2%
489
+9.2%
0.01%
+100.0%
Q1 2020$1,899,000
-18.4%
448
+17.3%
0.00%
-40.0%
Q4 2019$2,326,000
+109.5%
382
+41.0%
0.01%
+66.7%
Q3 2019$1,110,000
-15.2%
271
-2.5%
0.00%
-25.0%
Q2 2019$1,309,000
+112.2%
278
+60.7%
0.00%
+100.0%
Q1 2019$617,000
+228.2%
173
+162.1%
0.00%
+100.0%
Q4 2018$188,000
-20.0%
66
+24.5%
0.00%0.0%
Q3 2018$235,000
-77.3%
53
-69.9%
0.00%
-75.0%
Q2 2018$1,034,000
+363.7%
176
-59.4%
0.00%
-60.0%
Q1 2018$223,000
+1492.9%
434
+1346.7%
0.01%
+900.0%
Q4 2017$14,000
-48.1%
30
-43.4%
0.00%0.0%
Q3 2017$27,000530.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2021
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 310$2,279,0000.16%
GROUP ONE TRADING, L.P. 23,600$1,734,0000.01%
SIMPLEX TRADING, LLC 489$3,593,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders